Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date  ▴ Xconomist Location
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says Luke Timmerman 11/13/08 Boston
Biotech Survival Index: Cash Running Low at Seattle Life Sciences Companies Luke Timmerman 11/13/08 Seattle
Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker Ryan McBride 10/31/08 Boston
RXi Obtains License to RNAi Delivery Technology From UMass Medical School Luke Timmerman 10/14/08 Boston
AVI Biopharma Out to Reinvent Itself, Making RNA-based Drugs for Ebola and Other Nasty Things Luke Timmerman 09/10/08 Seattle
Alnylam’s In the Money: Expects $500 Million in Bank at Year-End Luke Timmerman 08/06/08 Boston
MDRNA Cuts 23 Jobs, Mostly in Nasal Delivery Business Luke Timmerman 08/05/08 Seattle
Alnylam Obtains Intellectual Property For RNA Activation, Turning Genes On Instead of Off Luke Timmerman 08/04/08 Boston
AVI Biopharma Hires New CFO, President On His Way Out Luke Timmerman 07/28/08 Seattle
RXi Takes a Untraditional Route to the Public Market, Now Working To Get Pharma to Pay The Bills Luke Timmerman 07/18/08 Boston
Dicerna Pharmaceuticals Raises Another $8.4 Million for Next-Generation RNAi Luke Timmerman 07/15/08 Boston
Big Drugmakers Pool Resources, Creating New Company Built to Improve R&D Luke Timmerman 07/10/08 Boston
Thermo Fisher Acquires Open Biosystems for RNAi Technology Luke Timmerman 07/01/08 Boston
Genzyme, Isis Finalize Partnership For Cholesterol-Lowering Drug Luke Timmerman 06/24/08 Boston
Page 1 of 1
    
Xconomy network map
Visit a city in our network or go to
Xconomy National
for network hightlights
Seattle Boston San Diego

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.